Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001411685-24-000048
Filing Date
2024-11-07
Accepted
2024-11-07 16:34:02
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtgn-20240930.htm   iXBRL 10-Q 1197211
2 EX-31.1 vtgn-20240930xexx311.htm EX-31.1 10133
3 EX-31.2 vtgn-20240930xexx312.htm EX-31.2 10059
4 EX-32 vtgn-20230930xexx32.htm EX-32 5234
  Complete submission text file 0001411685-24-000048.txt   4897030

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtgn-20240930.xsd EX-101.SCH 33879
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtgn-20240930_cal.xml EX-101.CAL 37493
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtgn-20240930_def.xml EX-101.DEF 136851
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtgn-20240930_lab.xml EX-101.LAB 492034
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtgn-20240930_pre.xml EX-101.PRE 316397
60 EXTRACTED XBRL INSTANCE DOCUMENT vtgn-20240930_htm.xml XML 429347
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 241436426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)